Completed OBSERVATIONAL NCT04119765

Plasma Oxalate in Patient With Short Bowel (OXAGO)

Sponsor: Hospices Civils de Lyon

Conditions Hyperoxalemia Hyperoxaluria Short Bowel Syndrome

Interventions Blood sampling Pulse Wave Velocity (PWV) measurement Urine sampling central pressure measurement

Updated 11 times since 2019 Last updated: Jul 20, 2022 Started: Feb 27, 2020 Primary completion: May 4, 2022 Completion: May 4, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Hyperoxalemia and Hyperoxaluria and is currently completed. Hospices Civils de Lyon leads this study, which shows 11 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jun 2022 — Sep 2022 [monthly]

Recruiting
Apr 2022 — Jun 2022 [monthly]

Recruiting

▶ Show 6 earlier versions

May 2021 — Apr 2022 [monthly]

Recruiting
Jan 2021 — May 2021 [monthly]

Recruiting
May 2020 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Mar 2020 — May 2020 [monthly]

Not Yet Recruiting
Feb 2020 — Mar 2020 [monthly]

Not Yet Recruiting
Nov 2019 — Feb 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospices Civils de Lyon

Data source: Hospices Civils de Lyon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lyon, France